scholarly journals Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck: A randomised phase II study

2019 ◽  
Vol 123 ◽  
pp. 36-47 ◽  
Author(s):  
Martin D. Forster ◽  
Magnus T. Dillon ◽  
Judit Kocsis ◽  
Éva Remenár ◽  
Gabor Pajkos ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Metastatic Squamous Cell Carcinoma

scholarly journals Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck

Cancer ◽  
2001 ◽  
Vol 92 (9) ◽  
pp. 2364-2373 ◽  
Author(s):  
Jennifer E. Tseng ◽  
Bonnie S. Glisson ◽  
Fadlo R. Khuri ◽  
Dong M. Shin ◽  
Jeffrey N. Myers ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Metastatic Squamous Cell Carcinoma

Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck

2013 ◽  
Vol 49 (13) ◽  
pp. 2877-2883 ◽  
Author(s):  
J.B. Vermorken ◽  
L. Licitra ◽  
J. Stöhlmacher-Williams ◽  
A. Dietz ◽  
J.M. Lopez-Picazo ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Metastatic Squamous Cell Carcinoma
Sign in / Sign up

Export Citation Format

Share Document